vs
Pediatrix Medical Group, Inc.（MD）とSCANSOURCE, INC.（SCSC）の財務データ比較。上の社名をクリックして会社を切り替えられます
SCANSOURCE, INC.の直近四半期売上が大きい（$766.5M vs $493.8M、Pediatrix Medical Group, Inc.の約1.6倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 2.2%、差は4.7%）。SCANSOURCE, INC.の前年同期比売上増加率が高い（2.5% vs -1.7%）。過去8四半期でSCANSOURCE, INC.の売上複合成長率が高い（0.9% vs -0.1%）
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
ScanSource社は世界有数の専門技術流通企業で、POSシステム、バーコードスキャナー、サイバーセキュリティ製品、クラウドサービス、通信ソリューションなどを取り扱い、北米・中南米・欧州の付加価値販売業者、サービスプロバイダー、企業顧客向けに事業を展開し、小売、医療、産業、公共部門を主な対象分野としています。
MD vs SCSC — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $493.8M | $766.5M |
| 純利益 | $33.7M | $16.5M |
| 粗利率 | — | 13.4% |
| 営業利益率 | 9.9% | 2.3% |
| 純利益率 | 6.8% | 2.2% |
| 売上前年比 | -1.7% | 2.5% |
| 純利益前年比 | 10.5% | -3.3% |
| EPS（希薄化後） | $0.40 | $0.75 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $493.8M | $766.5M | ||
| Q3 25 | $492.9M | $739.6M | ||
| Q2 25 | $468.8M | $812.9M | ||
| Q1 25 | $458.4M | $704.8M | ||
| Q4 24 | $502.4M | $747.5M | ||
| Q3 24 | $511.2M | $775.6M | ||
| Q2 24 | $504.3M | $746.1M | ||
| Q1 24 | $495.1M | $752.6M |
| Q4 25 | $33.7M | $16.5M | ||
| Q3 25 | $71.7M | $19.9M | ||
| Q2 25 | $39.3M | $20.1M | ||
| Q1 25 | $20.7M | $17.4M | ||
| Q4 24 | $30.5M | $17.1M | ||
| Q3 24 | $19.4M | $17.0M | ||
| Q2 24 | $-153.0M | $16.1M | ||
| Q1 24 | $4.0M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | 9.9% | 2.3% | ||
| Q3 25 | 13.8% | 3.5% | ||
| Q2 25 | 12.8% | 3.3% | ||
| Q1 25 | 7.0% | 3.2% | ||
| Q4 24 | 7.8% | 2.5% | ||
| Q3 24 | 6.6% | 2.3% | ||
| Q2 24 | -31.3% | 2.9% | ||
| Q1 24 | 3.2% | 2.3% |
| Q4 25 | 6.8% | 2.2% | ||
| Q3 25 | 14.5% | 2.7% | ||
| Q2 25 | 8.4% | 2.5% | ||
| Q1 25 | 4.5% | 2.5% | ||
| Q4 24 | 6.1% | 2.3% | ||
| Q3 24 | 3.8% | 2.2% | ||
| Q2 24 | -30.3% | 2.2% | ||
| Q1 24 | 0.8% | 1.7% |
| Q4 25 | $0.40 | $0.75 | ||
| Q3 25 | $0.84 | $0.89 | ||
| Q2 25 | $0.46 | $0.87 | ||
| Q1 25 | $0.24 | $0.74 | ||
| Q4 24 | $0.37 | $0.70 | ||
| Q3 24 | $0.23 | $0.69 | ||
| Q2 24 | $-1.84 | $0.66 | ||
| Q1 24 | $0.05 | $0.50 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $375.2M | $83.5M |
| 総負債低いほど良い | $570.5M | — |
| 株主資本純資産 | $865.9M | $910.9M |
| 総資産 | $2.2B | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | 0.66× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $375.2M | $83.5M | ||
| Q3 25 | $340.1M | $124.9M | ||
| Q2 25 | $224.7M | $126.2M | ||
| Q1 25 | $99.0M | $146.3M | ||
| Q4 24 | $229.9M | $110.5M | ||
| Q3 24 | $103.8M | $145.0M | ||
| Q2 24 | $19.4M | $185.5M | ||
| Q1 24 | $8.0M | $159.1M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $910.9M | ||
| Q3 25 | $890.7M | $914.0M | ||
| Q2 25 | $833.8M | $906.4M | ||
| Q1 25 | $789.2M | $901.7M | ||
| Q4 24 | $764.9M | $900.7M | ||
| Q3 24 | $732.5M | $920.9M | ||
| Q2 24 | $706.5M | $924.3M | ||
| Q1 24 | $856.2M | $944.1M |
| Q4 25 | $2.2B | $1.7B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $2.1B | $1.8B | ||
| Q1 25 | $2.0B | $1.7B | ||
| Q4 24 | $2.2B | $1.7B | ||
| Q3 24 | $2.1B | $1.8B | ||
| Q2 24 | $2.0B | $1.8B | ||
| Q1 24 | $2.2B | $1.8B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $114.1M | $30.8M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $28.9M |
| FCFマージンFCF / 売上 | — | 3.8% |
| 設備投資強度設備投資 / 売上 | — | 0.3% |
| キャッシュ転換率営業CF / 純利益 | 3.39× | 1.87× |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $114.1M | $30.8M | ||
| Q3 25 | $137.3M | $23.2M | ||
| Q2 25 | $137.2M | — | ||
| Q1 25 | $-117.5M | $66.1M | ||
| Q4 24 | $133.0M | $-6.2M | ||
| Q3 24 | $91.8M | $44.8M | ||
| Q2 24 | $107.0M | — | ||
| Q1 24 | $-125.2M | $160.2M |
| Q4 25 | — | $28.9M | ||
| Q3 25 | — | $20.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $64.6M | ||
| Q4 24 | — | $-8.2M | ||
| Q3 24 | — | $42.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $157.7M |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 21.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | 3.39× | 1.87× | ||
| Q3 25 | 1.91× | 1.17× | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | 3.79× | ||
| Q4 24 | 4.36× | -0.36× | ||
| Q3 24 | 4.72× | 2.64× | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | 12.51× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
